![](/img/cover-not-exists.png)
Antagonism of EGFR and HER3 Enhances the Response to Inhibitors of the PI3K-Akt Pathway in Triple-Negative Breast Cancer
Tao, J. J., Castel, P., Radosevic-Robin, N., Elkabets, M., Auricchio, N., Aceto, N., Weitsman, G., Barber, P., Vojnovic, B., Ellis, H., Morse, N., Viola-Villegas, N. T., Bosch, A., Juric, D., Hazra, SVolume:
7
Journal:
Science Signaling
DOI:
10.1126/scisignal.2005125
Date:
March, 2014
File:
PDF, 1.06 MB
2014